Filing Details
- Accession Number:
- 0001179110-21-002812
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 20:07:19
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 20:07:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1477449 | Teladoc Health Inc. | TDOC | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1375088 | C Adam Vandervoort | C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Legal Officer, Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-01 | 3,745 | $0.00 | 3,945 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-02 | 1,658 | $224.28 | 2,287 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-02 | 1,941 | $0.00 | 4,228 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-03-02 | 3,300 | $0.00 | 7,528 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2021-03-01 | 3,745 | $0.00 | 3,745 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2021-03-02 | 1,941 | $0.00 | 1,941 | $0.00 |
Common Stock | Performance Stock Units | Acquisiton | 2021-03-02 | 9,900 | $0.00 | 9,900 | $0.00 |
Common Stock | Performance Stock Units | Disposition | 2021-03-02 | 3,300 | $0.00 | 3,300 | $0.00 |
Common Stock | Restricted Stock Units | Acquisiton | 2021-03-02 | 5,736 | $0.00 | 5,736 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct | ||
3,883 | No | 4 | M | Direct | ||
9,900 | No | 4 | A | Direct | ||
6,600 | No | 4 | M | Direct | ||
5,736 | No | 4 | A | Direct |
Footnotes
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
- Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- On March 1, 2018, the reporting person was granted 11,236 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
- On March 2, 2020, the reporting person was granted 5,824 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
- Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- Performance award amount determined based on metrics in respect of the issuer's 2020 financial results.
- The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021.
- On March 2, 2021, the reporting person earned 9,900 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.
- Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
- The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date.